Parathyroid hormone 1 receptor is essential to induce FGF23 production and maintain systemic mineral ion homeostasis

FASEB Journal

Volumn 30, Issue 1, 2016, Pages 428-440

  Fan, Yi ^a,b   Bi, Ruiye ^b,c   Densmore, Michael J ^a   Sato, Tadatoshi ^a   Kobayashi, Tatsuya ^c   Yuan, Quan ^b   Zhou, Xuedong ^b   Erben, Reinhold G ^d   Lanske, Beate ^a,c  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^b SICHUAN UNIVERSITY   (China)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

Calcium phosphate metabolism; Galnt3; Kidney bone mineral diseases

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; MESSENGER RNA; PARATHYROID HORMONE RECEPTOR 1; PHOSPHATE; BETA GLUCURONIDASE; CALBINDIN; CALCIUM; FIBROBLAST GROWTH FACTOR; KLOTHO PROTEIN; N ACETYLGALACTOSAMINYLTRANSFERASE; NR4A2 PROTEIN, MOUSE; NUCLEAR RECEPTOR RELATED FACTOR 1; POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE;

ANIMAL TISSUE; ARTICLE; CALCIUM BALANCE; CALCIUM URINE LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HOMEOSTASIS; MALE; MESENCHYME; MINERAL ION HOMEOSTASIS; MOUSE; NONHUMAN; PHOSPHATE BALANCE; PHOSPHATE URINE LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; TRANSGENIC MOUSE; ANIMAL; BLOOD; BONE; BONE MINERALIZATION; GENETICS; KIDNEY; METABOLISM;

ANIMALS; BONE AND BONES; CALBINDINS; CALCIFICATION, PHYSIOLOGIC; CALCIUM; FEMALE; FIBROBLAST GROWTH FACTORS; GLUCURONIDASE; HOMEOSTASIS; KIDNEY; MALE; MICE; N-ACETYLGALACTOSAMINYLTRANSFERASES; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; PHOSPHATES; RECEPTOR, PARATHYROID HORMONE, TYPE 1; RNA, MESSENGER;

EID: 84974816061     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.15-278184     Document Type: Article

References (47)

1. Peacock, M. (2010) Calcium metabolism in health and disease. Clin. J. Am. Soc. Nephrol. 5(Suppl 1), S23-S30
2. Civitelli, R., and Ziambaras, K. (2011) Calcium and phosphate homeostasis: concerted interplay of new regulators. J. Endocrinol. Invest. 34(7, Suppl), 3-7
3. Murray, T. M., Rao, L. G., Divieti, P., and Bringhurst, F. R. (2005) Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands. Endocr. Rev. 26, 78-113
4. Gardella, T. J., and Jüppner, H. (2001) Molecular properties of the PTH/PTHrP receptor. Trends Endocrinol. Metab. 12, 210-217
5. Jüppner, H., Abou-Samra, A. B., Freeman, M., Kong, X. F., Schipani, E., Richards, J., Kolakowski, L. F., Jr., Hock, J., Potts, J. T., Jr., and Kronenberg, H. M., et al. (1991) A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254, 1024-1026
6. Lanske, B., Karaplis, A. C., Lee, K., Luz, A., Vortkamp, A., Pirro, A., Karperien, M., Defize, L. H., Ho, C., Mulligan, R. C., Abou-Samra, A. B., Jüppner, H., Segre, G. V., and Kronenberg, H. M. (1996) PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 273, 663-666
7. Kobayashi, T., Chung, U. I., Schipani, E., Starbuck, M., Karsenty, G., Katagiri, T., Goad, D. L., Lanske, B., and Kronenberg, H. M. (2002) PTHrP and Indian hedgehog control differentiation of growth plate chondrocytes at multiple steps. Development 129, 2977-2986
8. O'Brien, C. A., Plotkin, L. I., Galli, C., Goellner, J. J., Gortazar, A. R., Allen, M. R., Robling, A. G., Bouxsein, M., Schipani, E., Turner, C. H., Jilka, R. L., Weinstein, R. S., Manolagas, S. C., and Bellido, T. (2008) Control of bone mass and remodeling by PTH receptor signaling in osteocytes. PLoS One 3, e2942
9. Schipani, E., Lanske, B., Hunzelman, J., Luz, A., Kovacs, C. S., Lee, K., Pirro, A., Kronenberg, H. M., and Jüppner, H. (1997) Targeted expression of constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide delays endochondral bone formation and rescues mice that lack parathyroid hormone-related peptide. Proc. Natl. Acad. Sci. USA 94, 13689-13694
10. Guo, J., Chung, U. I., Kondo, H., Bringhurst, F. R., and Kronenberg, H. M. (2002) The PTH/PTHrP receptor can delay chondrocyte hypertrophy in vivo without activating phospholipase C. Dev. Cell 3, 183-194
11. Powell, W. F., Jr., Barry, K. J., Tulum, I., Kobayashi, T., Harris, S. E., Bringhurst, F. R., and Pajevic, P. D. (2011) Targeted ablation of the PTH/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses. J. Endocrinol. 209, 21-32
12. Qing, H., Ardeshirpour, L., Pajevic, P. D., Dusevich, V., Jähn, K., Kato, S., Wysolmerski, J., and Bonewald, L. F. (2012) Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation. J. Bone Miner. Res. 27, 1018-1029
13. Bounoutas, G. S., Tawfeek, H., Fröhlich, L. F., Chung, U. I., and Abou-Samra, A. B. (2006) Impact of impaired receptor internalization on calcium homeostasis in knock-in mice expressing a phosphorylation-deficient parathyroid hormone (PTH)/PTH-related peptide receptor. Endocrinology 147, 4674-4679
14. Soegiarto, D. W., Kiachopoulos, S., Schipani, E., Jüppner, H., Erben, R. G., and Lanske, B. (2001) Partial rescue of PTH/PTHrP receptor knockout mice by targeted expression of the Jansen transgene. Endocrinology 142, 5303-5310
15. White, K. E., Evans, W. E., O'Riordan, J. L. H., Speer, M. C., Econs, M. J., Lorenz-Depiereux, M., Grabowski, M., Meitinger, T., and Strom, T. M. (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat. Genet. 26, 345-348
16. Kato, K., Jeanneau, C., Tarp, M. A., Benet-Pagès, A., Lorenz-Depiereux, B., Bennett, E. P., Mandel, U., Strom, T. M., and Clausen, H. (2006) Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J. Biol. Chem. 281, 18370-18377
17. Larsson, T., Yu, X., Davis, S. I., Draman, M. S., Mooney, S. D., Cullen, M. J., and White, K. E. (2005) A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis. J. Clin. Endocrinol. Metab. 90, 2424-2427
18. Francis, F., Hennig, S., Korn, B., Reinhardt, R., de Jong, P., Poustka, A. Lehrach, H., Rowe, P.S.N, Goulding, J.N., Summerfield, T., Mountford R., Read, A.P., Popowska, E., Pronicka, E., Davies, K.E., O'Riordan, J.L.H., Econs, M.J., Nesbitt, T., Drezner, M.K., Oudet, C., Pannetier, S., Hanauer, A., Strom, T.M., Meindl, A., Lorenz, B., Cagnoli, B., Mohnike15, 16, J. Murken, K.L., and Meitinger, T. (1995) A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat. Genet. 11, 130-136
19. Nelson, A. E., Hogan, J. J., Holm, I. A., Robinson, B. G., and Mason, R. S. (2001) Phosphate wasting in oncogenic osteomalacia: PHEX is normal and the tumor-derived factor has unique properties. Bone 28, 430-439
20. Rhee, Y., Bivi, N., Farrow, E., Lezcano, V., Plotkin, L. I., White, K. E., and Bellido, T. (2011) Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo. Bone 49, 636-643
21. Kawata, T., Imanishi, Y., Kobayashi, K., Miki, T., Arnold, A., Inaba, M., and Nishizawa, Y. (2007) Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism. J. Am. Soc. Nephrol. 18, 2683-2688
22. Meir, T., Durlacher, K., Pan, Z., Amir, G., Richards, W. G., Silver, J., and Naveh-Many, T. (2014) Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription. Kidney Int. 86, 1106-1115
23. Lanske, B., and Razzaque, M. S. (2014) Molecular interactions of FGF23 and PTH in phosphate regulation. Kidney Int. 86, 1072-1074
24. Logan, M., Martin, J. F., Nagy, A., Lobe, C., Olson, E. N., and Tabin, C. J. (2002) Expression of Cre Recombinasein the developing mouse limb bud driven by a Prxl enhancer. Genesis 33, 77-80
25. McLeod, M. J. (1980) Differential staining of cartilage and bone in whole mouse fetuses by Alcian blue and alizarin red S. Teratology 22, 299-301
26. Dempster, D. W., Compston, J. E., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., Recker, R. R., and Parfitt, A. M. (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 28, 2-17
27. Yuan, Q., Jiang, Y., Zhao, X., Sato, T., Densmore, M., Schüler, C., Erben, R. G., McKee, M. D., and Lanske, B. (2014) Increased osteopontin contributes to inhibition of bone mineralization in FGF23-deficient mice. J. Bone Miner. Res. 29, 693-704
28. Katai, K., Miyamoto, K., Kishida, S., Segawa, H., Nii, T., Tanaka, H., Tani, Y., Arai, H., Tatsumi, S., Morita, K., Taketani, Y., and Takeda, E. (1999) Regulation of intestinal Na+-dependent phosphate cotransporters by a low-phosphate diet and 1,25-dihydroxyvitamin D3. Biochem. J. 343, 705-712
29. Liu, S., Guo, R., Simpson, L. G., Xiao, Z. S., Burnham, C. E., and Quarles, L. D. (2003) Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J. Biol. Chem. 278, 37419-37426
30. Virkki, L. V., Biber, J., Murer, H., and Forster, I. C. (2007) Phosphate transporters: a tale of two solute carrier families. Am. J. Physiol. Renal Physiol. 293, F643-F654
31. Beck, L., Karaplis, A. C., Amizuka, N., Hewson, A. S., Ozawa, H., and Tenenhouse, H. S. (1998) Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc. Natl. Acad. Sci. USA 95, 5372-5377
32. Yuan, Q., Sato, T., Densmore, M., Saito, H., Schüler, C., Erben, R. G., and Lanske, B. (2011) FGF-23/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH. J. Bone Miner. Res. 26, 2026-2035
33. Lanske, B., Amling, M., Neff, L., Guiducci, J., Baron, R., and Kronenberg, H. M. (1999) Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. J. Clin. Invest. 104, 399-407
34. Schipani, E., Kruse, K., and Jüppner, H. (1995) A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268, 98-100
35. Jobert, A. S., Zhang, P., Couvineau, A., Bonaventure, J., Roume, J., Le Merrer, M., and Silve, C. (1998) Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J. Clin. Invest. 102, 34-40
36. Karaplis, A. C., He, B., Nguyen, M. T., Young, I. D., Semeraro, D., Ozawa, H., and Amizuka, N. (1998) Inactivating mutation in the human parathyroid hormone receptor type 1 gene in Blomstrand chondrodysplasia. Endocrinology 139, 5255-5258
37. Shoback, D. (2007) Update in osteoporosis and metabolic bone disorders. J. Clin. Endocrinol. Metab. 92, 747-753
38. Mosekilde, L., Eriksen, E. F., and Charles, P. (1991) Hypercalcemia of malignancy: pathophysiology, diagnosis and treatment. Crit. Rev. Oncol. Hematol. 11, 1-27
39. Lanske, B., Divieti, P., Kovacs, C. S., Pirro, A., Landis, W. J., Krane, S. M., Bringhurst, F. R., and Kronenberg, H. M. (1998) The parathyroid hormone (PTH)/PTH-related peptide receptor mediates actions of both ligands in murine bone. Endocrinology 139, 5194-5204
40. Vortkamp, A., Lee, K., Lanske, B., Segre, G. V., Kronenberg, H. M., and Tabin, C. J. (1996) Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273, 613-622
41. Boros, S., Bindels, R. J., and Hoenderop, J. G. (2009) Active Ca(2+) reabsorption in the connecting tubule. Pflugers Arch. 458, 99-109
42. Olauson, H., Lindberg, K., Amin, R., Jia, T., Wernerson, A., Andersson, G., and Larsson, T. E. (2012) Targeted deletion of Klotho in kidney distal tubule disrupts mineral metabolism. J. Am. Soc. Nephrol. 23, 1641-1651
43. Forster, I. C., Hernando, N., Biber, J., and Murer, H. (2006) Proximal tubular handling of phosphate: a molecular perspective. Kidney Int. 70, 1548-1559
44. Brown, W. W., Jüppner, H., Langman, C. B., Price, H., Farrow, E. G., White, K. E., and McCormick, K. L. (2009) Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia. J. Clin. Endocrinol. Metab. 94, 17-20
45. Sato, T., Tominaga, Y., Ueki, T., Goto, N., Matsuoka, S., Katayama, A., Haba, T., Uchida, K., Nakanishi, S., Kazama, J. J., Gejyo, F., Yamashita, T., and Fukagawa, M. (2004) Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism. Am. J. Kidney Dis. 44, 481-487
46. Lavi-Moshayoff, V., Wasserman, G., Meir, T., Silver, J., and Naveh-Many, T. (2010) PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am. J. Physiol. Renal Physiol. 299, F882-F889
47. Tagliabracci, V. S., Engel, J. L., Wiley, S. E., Xiao, J., Gonzalez, D. J., Nidumanda Appaiah, H., Koller, A., Nizet, V., White, K. E., and Dixon, J. E. (2014) Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis. Proc. Natl. Acad. Sci. USA 111, 5520-5525